Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis

Study:

An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis

Rationale:

n/a

Purpose:

The purpose of this study is to examine the long-term safety of Abatacept for the treatment of juvenile idiopathic arthritis (JIA) in routine clinical practice, with particular in interest in the occurrence of serious infections, autoimmune disorders, and malignancies.

Study Status: Recruiting

Recruiting:
Steve Spaulding, Site 006 216-444-3701

Condition Intervention Phase
Juvenile Idiopathic Arthritis n/a N/A

Verified by Bristol-Myers Squibb November, 2013

Sponsored by: Bristol-Myers Squibb
Information provided by: Bristol-Myers Squibb
ClinicalTrials.gov identifier: NCT01357668

Study Type: Interventional

Study Design: Observational Model: Cohort, Time Perspective: Prospective

Cleveland Clinic
Cleveland, Ohio 44195
United States

Bristol-Myers Squibb., Study Director

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site